Neos Therapeutics plans common stock offering
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Neos Therapeutics Inc. initiated an underwritten public offering of its common shares.
Neos plans to grant underwriters the option to purchase up to an additional 15% of the number of common shares sold in the offering.
Cowen and Co. and BMO Capital Markets are acting as joint book-running managers for the offering.